Literature DB >> 212759

Endogenous RNA tumor viruses are activated during chemical induction of murine plasmacytomas.

M Y Armstrong, P Ebenstein, W H Konigsberg, F F Richards.   

Abstract

Plasmacytomas are induced in BALB/c mice by the intraperitoneal injection of pristane (2,6,10,14-tetra-methylpentadecane) after a latent period of six months and more [Anderson, P. N. & Potter, M. (1969) Nature 222, 994-995]. Spleen cells mesenteric lymph node cells, thoracic lymph node cells, and peritoneal exudate cells were prepared from pristane-treated and control uninjected BALB/c mice during the course of a 10-month period, and these cell suspensions were tested for the release of infectious murine leukemia viruses. Endogenous ecotropic and xenotropic murine leukemia viruses were expressed in pristane-treated mice during the latter part of the tumor induction period, in those cell populations in which transformed plasma cells appear, namely, peritoneal exudate cells and thoracic lymph node cells. The significance of preferential expression of both ecotropic and xenotropic murine leukemia virus in target cell populations following the administration of a carcinogen is discussed in terms of the possible formation of an oncogenic variant virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212759      PMCID: PMC336154          DOI: 10.1073/pnas.75.9.4549

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Induction of plasma-cell neoplasms and fibrosarcomas in BALB/c mice carrying diffusion chambers.

Authors:  R M MERWIN; G H ALGIRE
Journal:  Proc Soc Exp Biol Med       Date:  1959-07

2.  HISTOLOGY OF DEVELOPING PLASMA CELL NEOPLASIA INDUCED BY MINERAL OIL IN BALB/C MICE.

Authors:  M POTTER; R C MACCARDLE
Journal:  J Natl Cancer Inst       Date:  1964-09       Impact factor: 13.506

3.  Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants.

Authors:  J H Elder; J W Gautsch; F C Jensen; R A Lerner; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

Review 4.  Strategy for detection of cancer hazards to man.

Authors:  R Doll
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

5.  Role of endogenous murine leukemia virus in immunologically triggered lymphoreticular tumors. I. Development and use of oncogenic cellfree preparations serially passaged in vivo.

Authors:  M Y Armstrong; N H Ruddle; M B Lipman; S K Pierce; F F Richards
Journal:  J Natl Cancer Inst       Date:  1977-01       Impact factor: 13.506

6.  Expression of endogenous murine leukemia viruses during the course of a protracted immunological disorder.

Authors:  M Y Armstrong; N H Ruddle; F F Richards
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

7.  Surface antigens on transplantable tumor cell lines producing mouse type C viruses.

Authors:  T Aoki; R B Herberman; J W Hartley; M Liu; M J Walling; M Nunn
Journal:  J Natl Cancer Inst       Date:  1977-04       Impact factor: 13.506

8.  Mechanism of restriction of ecotropic and xenotropic murine leukemia viruses and formation of pseudotypes between the two viruses.

Authors:  P Besmer; D Baltimore
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

9.  A new class of murine leukemia virus associated with development of spontaneous lymphomas.

Authors:  J W Hartley; N K Wolford; L J Old; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice.

Authors:  K Kawashima; H Ikeda; J W Hartley; E Stockert; W P Rowe; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

View more
  11 in total

1.  Isolation and characterization of a family of rat endogenous retroviral sequences.

Authors:  M Nakamuta; M Furuich; K Takahashi; N Suzuki; H Endo; M Yamamoto
Journal:  Virus Genes       Date:  1989-09       Impact factor: 2.332

2.  Transformation of NIH 3T3 cells by DNA of the MCF-7 human mammary carcinoma cell line induces expression of an endogenous murine leukemia provirus.

Authors:  D Becker; M A Lane; G M Cooper
Journal:  Mol Cell Biol       Date:  1984-11       Impact factor: 4.272

3.  RNA virus expression during and after methylnitrosourea-induced T-cell leukemogenesis in mice.

Authors:  M Grompe; L Kreja; J Schmidt; H J Seidel
Journal:  Blut       Date:  1985-12

4.  Thyroid or glucocorticoid hormone induces pre-growth-hormone mRNA and its probable nuclear precursor in rat pituitary cells.

Authors:  P R Dobner; E S Kawasaki; L Y Yu; F C Bancroft
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

5.  Autoimmune targeting of key components of RNA interference.

Authors:  Andrew Jakymiw; Keigo Ikeda; Marvin J Fritzler; Westley H Reeves; Minoru Satoh; Edward K L Chan
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

6.  Effect of MuLV-related genes on plasmacytomagenesis in BALB/c mice.

Authors:  M Potter; J W Hartley; J S Wax; D Gallahan
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

7.  Expression of endogenous xenotropic retrovirus by methylcholanthrene-induced squamous cell carcinoma of the mouse respiratory tract.

Authors:  P Ebenstein; B Kinder; D O Bankole; F F Richards; M Y Armstrong
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 17.579

8.  Insertional hypermutation in mineral oil-induced plasmacytomas.

Authors:  Gero Knittel; Mirjam Metzner; Gabriele Beck-Engeser; Ada Kan; Tomasz Ahrends; Dan Eilat; Konrad Huppi; Matthias Wabl
Journal:  Eur J Immunol       Date:  2014-09       Impact factor: 6.688

9.  Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane.

Authors:  M Satoh; W H Reeves
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

10.  Down-regulation of osteopontin attenuates breast tumour progression in vivo.

Authors:  Goutam Chakraborty; Shalini Jain; Tushar V Patil; Gopal C Kundu
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.